Management and referral of COVID-19 cases
Attention: Healthcare Practitioners
Here is the updated DOH guidelines on the management and referrals of suspected and confirmed COVID-19 cases under Code Red.
Attention: Healthcare Practitioners
Here is the updated DOH guidelines on the management and referrals of suspected and confirmed COVID-19 cases under Code Red.
Urinary tract infections (UTI) are among the leading indications for seeking healthcare and using antimicrobials in the community and hospital settings. The Philippine Clinical Practice Guidelines on the Diagnosis and Management of Urinary Tract Infections in Adults were first published in 1998 and revised in 2004 to provide primary care physicians and specialists with evidence-based recommendations on the care of patients with UTI. The current guidelines further update the recommendations following an extensive review of more recent literature. For the first time the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) system was used to develop guidelines in infectious diseases in the country. The outputs are consensus recommendations of a panel of clinicians convened by the Philippine Society for Microbiology and Infectious Diseases (PSMID) in collaboration with the Philippine Obstetric and Gynecological Society (POGS), Philippine Society of Nephrology (PSN), Philippine Academy of Family Physicians (PAFP), and Philippine Urological Association (PUA).
The focus of the guidelines is on diagnosis, treatment, and prevention of UTI in adults and consists of two parts:
Part One – Acute Uncomplicated UTI and UTI in Pregnancy
Part Two – Asymptomatic Bacteriuria, Recurrent UTI and Complicated UTI
DOWNLOAD the Clinical Practice Guidelines for UTI in Adults 2015 Update: Part 2
Urinary tract infections (UTI) were among the leading indications for seeking healthcare and using antimicrobials in the community and hospital settings. The Philippine Clinical Practice Guidelines on the Diagnosis and Management of Urinary Tract Infections in Adults were first published in 1998 and revised in 2004 to provide primary care physicians and specialists with evidence-based recommendations on the care of patients with UTI. The current guidelines further updated the recommendations following an extensive review of more recent literature. This was the first time that the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) system was used to develop guidelines in infectious diseases in the country. The outputs were consensus recommendations of a panel of clinicians convened by the Philippine Society for Microbiology and Infectious Diseases (PSMID) in collaboration with the Philippine Obstetric and Gynecological Society (POGS), Philippine Society of Nephrology (PSN), Philippine Academy of Family Physicians (PAFP), and Philippine Urological Association (PUA).
The focus of the guidelines was on diagnosis, treatment, and prevention of UTI in adults and consists of two parts:
Part One – Acute Uncomplicated UTI and UTI in Pregnancy
Part Two – Asymptomatic Bacteriuria, Recurrent UTI and Complicated UTI
DOWNLOAD the Clinical Practice Guidelines for UTI in Adults 2013 Update: Part 1
Typhoid fever is still a major problem with a reported global burden estimate of 26.9 million cases in 2010 with a case fatality rate of 1%. The Philippines had 2,025 cases of typhoid and paratyphoid fever in 2010, a marked decrease from the 2003 figure of 16,444 cases. Morbidity is 30.5/100,000 population and mortality is 1.7/100,000 population.
To help clinicians in the diagnosis and management typhoid fever, the Philippine Society for Microbiology and Infectious Diseases (PSMID) formulated this clinical practice guidelines to:
DOWNLOAD the Clinical Practice Guidelines for Typhoid Fever in Adults 2017 here.
This document is intended for practicing clinicians and other healthcare professionals involved in the holistic care of adult patients with presumptive or confirmed tuberculosis (TB), updating the 2006 Philippine Clinical Practice Guidelines on the Diagnosis, Treatment, Prevention and Control of Tuberculosis. Its timely release comes after the recent revision of the National Tuberculosis Control Program (NTP) Manual of Procedures (MOP) 5th Edition of the Department of Health (DOH), the 2014 International Standards for Tuberculosis Care (ISTC) and recent TB policies and statements released by the World Health Organization (WHO) since 2006.
This document has the following objectives:
To update the 2006 Philippine Clinical Practice Guidelines on TB in Adults with recent medical evidence (2005-2015) in light of new developments at the global level, further localized in the Philippine setting, which will serve as useful tool to assist clinicians and other TB personnel to standardize diagnosis and management of TB among adult Filipinos;
To harmonize with and complement the NTP-MOP by providing medical evidence to support its policies, with focus on local data where available, in order to facilitate acceptance and compliance among private healthcare providers; and
To identify new and relevant TB-related issues and areas for future research in the diagnosis, treatment, prevention and control of TB among immunocompetent and high risk clinical groups in the Philippine setting.
DOWNLOAD the Clinical Practice Guidelines for Tuberculosis in Adult Filipinos 2016 here.
This Administrative Order is to update the guidelines on post-exposure prophylaxis and Pre-Exposure Prophylaxis of rabies and to provide guidance on the selection and use of human rabies vaccine to help address the global shortage of World Health Organization (WHO) pre-qualified human rabies vaccines.
DOWNLOAD the Clinical Practice Guidelines for Rabies Exposures AO 2018-0013 here.
This updated guideline is intended to guide health care practitioners in the early recognition, prompt management, and prevention of leptospirosis and its complications in primary, secondary, and tertiary health facilities. The guideline also aims to heighten the awareness and index of suspicion of clinicians not just during an outbreak but also during the rainy months and in cases associated with travel, recreational sports, and occupational exposures.
DOWNLOAD the Clinical Practice Guidelines for Leptospirosis 2010 here.
The objective of this guideline is to provide a framework for the treatment of Filipino HIV patients using an evidence-based approach, with emphasis on locally available treatment. The target audience is not only the infectious diseases subspecialist who treats HIV but also internists, family physicians, pulmonary specialists and other subspecialists who are taking care of or who wish to care for persons living with HIV.
Guidance on the management of HIV-infected healthcare workers in the Philippines. Recommendations to guide physicians and hospital administrators involved in the management of HIV-infected healthcare workers.
The main objective of this paper is to provide an ethical and legal framework in managing the HIV-infected healthcare worker, balancing the rights and safety of both the patient and the healthcare provider.
Internationally, community-acquired pneumonia (CAP) remains the leading cause of death from an infectious disease. It is the sixth leading cause of death overall and is a major cause of morbidity and mortality. Since the last publication of Philippine Clinical Practice Guidelines on the Diagnosis, Empiric Management, and Prevention of Community-acquired Pneumonia (CAP) in Immunocompetent Adults in 2010, several changes had emerged:
Multiple international societies had published and revised their guidelines of the management of patients with CAP.
New organisms had emerged and development of resistance had increased over time among respiratory pathogens.
The influx and efflux of antimicrobial agents used in the treatment had likewise posed a threat to the rapid rise of antimicrobial resistance. The use, misuse, abuse and overuse had also shaken the market of antimicrobial agents.
It is for these reasons that a long overdue update on the management of CAP is needed. There is a need to standardize care by providing management strategies based on best available evidences. The evidences may be the same; however, regional differences, causative agents, antibiotic resistance rates, drug licensing, healthcare structure and available resources may vary. Recommendations made by one national organization may therefore not be applicable to other countries
Dr. Jemelyn Garcia, FPCP, FPSMID
Dr. Maria Sonia Salamat, FPCP, FPSMID
Dr. Marja B. Buensalido, FPCP, FPSMID
Dr. Emmerson Gale Vista, FPDS
Dr. Clarisse Garcia-Mendoza, FPDS
Dr. Kingbherly L. Li, FPCP, FPSMID
Dr. Yvette Silubrico, FPCP, FPSMID
Dr. Chatie Olasiman, FPCP, FPSMID
Dr. Ma. Charmian Hufano, FPCP, FPSMID
Dr. Mitzie Lou Osabel, FPCP, FPSMID
Dr. Janice C. Caoili, FPCP, FPSMID
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.